ClinicalTrials.Veeva

Menu

Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine

Z

Zhejiang Provincial Center for Disease Control and Prevention

Status

Completed

Conditions

Varicocele

Treatments

Biological: live attenuated varicella vaccine

Study type

Observational

Funder types

Other

Identifiers

NCT02983656
ZJCDC20161121

Details and patient eligibility

About

The purpose of this study is to observe the occurrence of adverse events of live attenuated varicella vaccine.

Enrollment

394 patients

Sex

All

Ages

1 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The registered permanent residence or resident place are local (reside more than 3 months);
  • Participant preventive inoculation of varicella vaccine in 2014-2015;
  • Adverse reactions occurred and should be reported in the AEFI monitoring system.

Exclusion criteria

  • Subjects with a known allergy to any ingredient of the vaccine, and with any allergy history to any vaccine;
  • Subjects with any acute diseases, severe chronic diseases, acute bout of chronic diseases, and catching cold and fever;
  • Subjects with uncontrolled seizures and other progressive neurological diseases, with a history of Guillain-Barré syndrome.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems